Progesterone antagonist therapy in a pelizaeus-merzbacher mouse model

American Journal of Human Genetics

Volumn 94, Issue 4, 2014, Pages 533-546

  Prukop, Thomas ^a   Epplen, Dirk B ^a   Nientiedt, Tobias ^a   Wichert, Sven P ^a,b   Fledrich, Robert ^a   Stassart, Ruth M ^a,c   Rossner, Moritz J ^a,b   Edgar, Julia M ^a   Werner, Hauke B ^a   Nave, Klaus Armin ^a   Sereda, Michael W ^a,c  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LONAPRISAN; MESSENGER RNA; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ELECTRON MICROSCOPY; GENE; GENE EXPRESSION; GLIOSIS; HISTOPATHOLOGY; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MYELINATED NERVE; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PHENOTYPE; PLP1 GENE; PRIORITY JOURNAL; PYRAMIDAL TRACT; THERAPY EFFECT;

MUS;

ANIMALS; DISEASE MODELS, ANIMAL; ESTRENES; GENE EXPRESSION REGULATION; HORMONE ANTAGONISTS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN PROTEOLIPID PROTEIN; PELIZAEUS-MERZBACHER DISEASE; PHENOTYPE; PROGESTERONE; RNA, MESSENGER;

EID: 84898012507     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2014.03.001     Document Type: Article

References (89)

1. F. Seitelberger Neuropathology and genetics of Pelizaeus-Merzbacher disease Brain Pathol. 5 1995 267 273
2. D.A. Yool, J.M. Edgar, P. Montague, and S. Malcolm The proteolipid protein gene and myelin disorders in man and animal models Hum. Mol. Genet. 9 2000 987 992 (Pubitemid 30216110)
3. A.H. Koeppen, and Y. Robitaille Pelizaeus-Merzbacher disease J. Neuropathol. Exp. Neurol. 61 2002 747 759 (Pubitemid 35001347)
4. J.Y. Garbern Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis Cell. Mol. Life Sci. 64 2007 50 65 (Pubitemid 46159445)
5. F.I. Gruenenfelder, G. Thomson, J. Penderis, and J.M. Edgar Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease J. Anat. 219 2011 33 43
6. F. Cailloux, F. Gauthier-Barichard, C. Mimault, V. Isabelle, V. Courtois, G. Giraud, B. Dastugue, O. Boespflug-Tanguy Clinical European Network on Brain Dysmyelinating Disease Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations Eur. J. Hum. Genet. 8 2000 837 845
7. K. Al-Saktawi, M. McLaughlin, M. Klugmann, A. Schneider, J.A. Barrie, M.C. McCulloch, P. Montague, D. Kirkham, K.A. Nave, and I.R. Griffiths Genetic background determines phenotypic severity of the Plp rumpshaker mutation J. Neurosci. Res. 72 2003 12 24 (Pubitemid 36373807)
8. K.J. Woodward The molecular and cellular defects underlying Pelizaeus-Merzbacher disease Expert Rev. Mol. Med. 10 2008 e14
9. O. Jahn, S. Tenzer, and H.B. Werner Myelin proteomics: molecular anatomy of an insulating sheath Mol. Neurobiol. 40 2009 55 72
10. P. Saugier-Veber, A. Munnich, D. Bonneau, J.M. Rozet, M. Le Merrer, R. Gil, and O. Boespflug-Tanguy X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus Nat. Genet. 6 1994 257 262 (Pubitemid 24188622)
11. L.D. Hudson Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene J. Child Neurol. 18 2003 616 624 (Pubitemid 37258467)
12. K.-A. Nave, and I.R. Griffiths Models of Pelizaeus-Merzbacher disease R.A. Lazzarini, J.W. Griffin, H. Lassmann, K.-A. Nave, R.H. Miller, B.D. Trapp, Myelin Biology and Disorders 2004 Elsevier Amsterdam 1125 1142
13. K. Inoue PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2 Neurogenetics 6 2005 1 16 (Pubitemid 40394825)
14. K. Woodward, E. Kendall, D. Vetrie, and S. Malcolm Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH Am. J. Hum. Genet. 63 1998 207 217 (Pubitemid 30428337)
15. N.I. Wolf, E.A. Sistermans, M. Cundall, G.M. Hobson, A.P. Davis-Williams, R. Palmer, P. Stubbs, S. Davies, M. Endziniene, and Y. Wu et al. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease Brain 128 2005 743 751 (Pubitemid 40516913)
16. A.M. Schneider, I.R. Griffiths, C. Readhead, and K.A. Nave Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein Proc. Natl. Acad. Sci. USA 92 1995 4447 4451
17. A. Gow, and R.A. Lazzarini A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease Nat. Genet. 13 1996 422 428 (Pubitemid 26256615)
18. M. Jung, I. Sommer, M. Schachner, and K.A. Nave Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice J. Neurosci. 16 1996 7920 7929 (Pubitemid 26405055)
19. M. Simons, E.M. Kramer, P. Macchi, S. Rathke-Hartlieb, J. Trotter, K.A. Nave, and J.B. Schulz Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease J. Cell Biol. 157 2002 327 336 (Pubitemid 34839828)
20. E.M. Krämer-Albers, K. Gehrig-Burger, C. Thiele, J. Trotter, and K.A. Nave Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia J. Neurosci. 26 2006 11743 11752 (Pubitemid 44772145)
21. S.A. Karim, J.A. Barrie, M.C. McCulloch, P. Montague, J.M. Edgar, D.L. Iden, T.J. Anderson, K.A. Nave, I.R. Griffiths, and M. McLaughlin PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease Glia 58 2010 1727 1738
22. M. Klugmann, M.H. Schwab, A. Pühlhofer, A. Schneider, F. Zimmermann, I.R. Griffiths, and K.A. Nave Assembly of CNS myelin in the absence of proteolipid protein Neuron 18 1997 59 70 (Pubitemid 27053830)
23. I. Griffiths, M. Klugmann, T. Anderson, D. Yool, C. Thomson, M.H. Schwab, A. Schneider, F. Zimmermann, M. McCulloch, N. Nadon, and K.A. Nave Axonal swellings and degeneration in mice lacking the major proteolipid of myelin Science 280 1998 1610 1613 (Pubitemid 28278256)
24. J.Y. Garbern, F. Cambi, R. Lewis, M. Shy, A. Sima, G. Kraft, J.M. Vallat, E.P. Bosch, M.E. Hodes, and S. Dlouhy et al. Peripheral neuropathy caused by proteolipid protein gene mutations Ann. N Y Acad. Sci. 883 1999 351 365 (Pubitemid 129495444)
25. J.M. Edgar, M. McLaughlin, D. Yool, S.C. Zhang, J.H. Fowler, P. Montague, J.A. Barrie, M.C. McCulloch, I.D. Duncan, and J. Garbern et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia J. Cell Biol. 166 2004 121 131 (Pubitemid 38931922)
26. H.B. Werner, E.M. Krämer-Albers, N. Strenzke, G. Saher, S. Tenzer, Y. Ohno-Iwashita, P. De Monasterio-Schrader, W. Möbius, T. Moser, I.R. Griffiths, and K.A. Nave A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system Glia 61 2013 567 586
27. S.A. Karim, J.A. Barrie, M.C. McCulloch, P. Montague, J.M. Edgar, D. Kirkham, T.J. Anderson, K.A. Nave, I.R. Griffiths, and M. McLaughlin PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease Glia 55 2007 341 351
28. G. Saher, F. Rudolphi, K. Corthals, T. Ruhwedel, K.F. Schmidt, S. Löwel, P. Dibaj, B. Barrette, W. Möbius, and K.A. Nave Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet Nat. Med. 18 2012 1130 1135
29. T. Kagawa, K. Ikenaka, Y. Inoue, S. Kuriyama, T. Tsujii, J. Nakao, K. Nakajima, J. Aruga, H. Okano, and K. Mikoshiba Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene Neuron 13 1994 427 442 (Pubitemid 24275099)
30. C. Readhead, A. Schneider, I. Griffiths, and K.A. Nave Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage Neuron 12 1994 583 595 (Pubitemid 24100889)
31. Y. Inoue, T. Kagawa, Y. Matsumura, K. Ikenaka, and K. Mikoshiba Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage Neurosci. Res. 25 1996 161 172 (Pubitemid 26232015)
32. T.J. Anderson, M. Klugmann, C.E. Thomson, A. Schneider, C. Readhead, K.A. Nave, and I.R. Griffiths Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication Ann. N Y Acad. Sci. 883 1999 234 246 (Pubitemid 129495432)
33. M. Bradl, J. Bauer, T. Inomata, J. Zielasek, K.A. Nave, K. Toyka, H. Lassmann, and H. Wekerle Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis Acta Neuropathol. 97 1999 595 606 (Pubitemid 29231677)
34. T.J. Anderson, A. Schneider, J.A. Barrie, M. Klugmann, M.C. McCulloch, D. Kirkham, E. Kyriakides, K.A. Nave, and I.R. Griffiths Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene J. Comp. Neurol. 394 1998 506 519 (Pubitemid 28183573)
35. M. Cerghet, D.A. Bessert, K.A. Nave, and R.P. Skoff Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways J. Neurocytol. 30 2001 841 855 (Pubitemid 33816151)
36. J.M. Edgar, M.C. McCulloch, P. Montague, A.M. Brown, S. Thilemann, L. Pratola, F.I. Gruenenfelder, I.R. Griffiths, and K.A. Nave Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease EMBO Mol. Med. 2 2010 42 50
37. M.W. Sereda, G. Meyer zu Hörste, U. Suter, N. Uzma, and K.A. Nave Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) Nat. Med. 9 2003 1533 1537 (Pubitemid 38004782)
38. H.L. Koenig, M. Schumacher, B. Ferzaz, A.N. Thi, A. Ressouches, R. Guennoun, I. Jung-Testas, P. Robel, Y. Akwa, and E.E. Baulieu Progesterone synthesis and myelin formation by Schwann cells Science 268 1995 1500 1503
39. F. Désarnaud, A.N. Do Thi, A.M. Brown, G. Lemke, U. Suter, E.E. Baulieu, and M. Schumacher Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells J. Neurochem. 71 1998 1765 1768 (Pubitemid 28443052)
40. R. Guennoun, Y. Benmessahel, B. Delespierre, M. Gouézou, K.M. Rajkowski, E.E. Baulieu, and M. Schumacher Progesterone stimulates Krox-20 gene expression in Schwann cells Brain Res. Mol. Brain Res. 90 2001 75 82 (Pubitemid 32497174)
41. V. Magnaghi, M. Ballabio, A. Consoli, J.J. Lambert, I. Roglio, and R.C. Melcangi GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids J. Mol. Neurosci. 28 2006 89 102 (Pubitemid 43780339)
42. V. Magnaghi, M. Ballabio, I. Roglio, and R.C. Melcangi Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells J. Mol. Neurosci. 31 2007 149 157 (Pubitemid 46742298)
43. M. Schumacher, R. Hussain, N. Gago, J.P. Oudinet, C. Mattern, and A.M. Ghoumari Progesterone synthesis in the nervous system: implications for myelination and myelin repair Front. Neurosci. 6 2012 10
44. I. Jung-Testas, M. Schumacher, P. Robel, and E.E. Baulieu The neurosteroid progesterone increases the expression of myelin proteins (MBP and CNPase) in rat oligodendrocytes in primary culture Cell. Mol. Neurobiol. 16 1996 439 443 (Pubitemid 26231273)
45. A.M. Ghoumari, C. Ibanez, M. El-Etr, P. Leclerc, B. Eychenne, B.W. O'Malley, E.E. Baulieu, and M. Schumacher Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum J. Neurochem. 86 2003 848 859 (Pubitemid 36988797)
46. C. Ibanez, S.A. Shields, M. El-Etr, E.E. Baulieu, M. Schumacher, and R.J. Franklin Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats Neuropathol. Appl. Neurobiol. 30 2004 80 89 (Pubitemid 38178005)
47. N. Gago, M. El-Etr, N. Sananès, F. Cadepond, D. Samuel, V. Avellana-Adalid, A. Baron-Van Evercooren, and M. Schumacher 3alpha,5alpha- Tetrahydroprogesterone (allopregnanolone) and gamma-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ progenitor proliferation J. Neurosci. Res. 78 2004 770 783 (Pubitemid 39657565)
48. A.M. Ghoumari, E.E. Baulieu, and M. Schumacher Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures Neuroscience 135 2005 47 58 (Pubitemid 41219737)
49. F. Labombarda, S.L. González, A. Lima, P. Roig, R. Guennoun, M. Schumacher, and A.F. de Nicola Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury Glia 57 2009 884 897
50. P. Acs, M. Kipp, A. Norkute, S. Johann, T. Clarner, A. Braun, Z. Berente, S. Komoly, and C. Beyer 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice Glia 57 2009 807 814
51. U. Fuhrmann, H. Hess-Stumpp, A. Cleve, G. Neef, W. Schwede, J. Hoffmann, K.H. Fritzemeier, and K. Chwalisz Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist J. Med. Chem. 43 2000 5010 5016 (Pubitemid 32039022)
52. U. Karlsson, and R.L. Schultz Fixation of the central nervous system from electron microscopy by aldehyde perfusion. I. Preservation with aldehyde perfusates versus direct perfusion with osmium tetroxide with special reference to membranes and the extracelluar space J. Ultrastruct. Res. 12 1965 160 186
53. U. Suter, G.J. Snipes, R. Schoener-Scott, A.A. Welcher, S. Pareek, J.R. Lupski, R.A. Murphy, E.M. Shooter, and P.I. Patel Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters J. Biol. Chem. 269 1994 25795 25808 (Pubitemid 24336279)
54. R.A. van de Wetering, A.A. Gabreëls-Festen, H. Kremer, V.M. Kalscheuer, F.J. Gabreëls, and E.C. Mariman Regulation and expression of the murine PMP22 gene Mamm. Genome 10 1999 419 422 (Pubitemid 29390500)
55. Y. Ohsawa, T. Murakami, Y. Miyazaki, T. Shirabe, and Y. Sunada Peripheral myelin protein 22 is expressed in human central nervous system J. Neurol. Sci. 247 2006 11 15 (Pubitemid 44107377)
56. V.K. Mootha, C.M. Lindgren, K.F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, and E. Laurila et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat. Genet. 34 2003 267 273 (Pubitemid 36792858)
57. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550 (Pubitemid 41528093)
58. J.G. Kim, and L.D. Hudson Novel member of the zinc finger superfamily: A C2-HC finger that recognizes a glia-specific gene Mol. Cell. Biol. 12 1992 5632 5639
59. E. Wang, and F. Cambi MicroRNA expression in mouse oligodendrocytes and regulation of proteolipid protein gene expression J. Neurosci. Res. 90 2012 1701 1712
60. O.E. Zolova, and P.A. Wight YY1 negatively regulates mouse myelin proteolipid protein (Plp1) gene expression in oligodendroglial cells ASN Neuro 3 2011 3
61. K.A. Nave, and G. Lemke Induction of the myelin proteolipid protein (PLP) gene in C6 glioblastoma cells: functional analysis of the PLP promotor J. Neurosci. 11 1991 3060 3069
62. R. Janz, and W. Stoffel Characterization of a brain-specific Sp1-like activity interacting with an unusual binding site within the myelin proteolipid protein promoter Biol. Chem. Hoppe Seyler 374 1993 507 517
63. J.A. Berndt, J.G. Kim, M. Tosic, C. Kim, and L.D. Hudson The transcriptional regulator Yin Yang 1 activates the myelin PLP gene J. Neurochem. 77 2001 935 942 (Pubitemid 32466790)
64. A. Dobretsova, J.W. Johnson, R.C. Jones, R.D. Edmondson, and P.A. Wight Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene J. Neurochem. 105 2008 1979 1995 (Pubitemid 351695373)
65. M.C. Tuason, A. Rastikerdar, T. Kuhlmann, C. Goujet-Zalc, B. Zalc, S. Dib, H. Friedman, and A. Peterson Separate proteolipid protein/DM20 enhancers serve different lineages and stages of development J. Neurosci. 28 2008 6895 6903
66. I. Jung-Testas, A. Do Thi, H. Koenig, F. Désarnaud, K. Shazand, M. Schumacher, and E.E. Baulieu Progesterone as a neurosteroid: synthesis and actions in rat glial cells J. Steroid Biochem. Mol. Biol. 69 1999 97 107 (Pubitemid 29305527)
67. J.D. Blaustein Progestin receptors: neuronal integrators of hormonal and environmental stimulation Ann. N Y Acad. Sci. 1007 2003 238 250 (Pubitemid 38253670)
68. E.E. Baulieu Neurosteroids: of the nervous system, by the nervous system, for the nervous system Recent Prog. Horm. Res. 52 1997 1 32 (Pubitemid 127470204)
69. M. Schumacher, R. Guennoun, F. Robert, C. Carelli, N. Gago, A. Ghoumari, M.C. Gonzalez Deniselle, S.L. Gonzalez, C. Ibanez, and F. Labombarda et al. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination Growth Horm. IGF Res. 14 Suppl A 2004 S18 S33
70. N.J. MacLusky, and B.S. McEwen Progestin receptors in the developing rat brain and pituitary Brain Res. 189 1980 262 268 (Pubitemid 10146501)
71. A.H. Lauber, G.J. Romano, and D.W. Pfaff Gene expression for estrogen and progesterone receptor mRNAs in rat brain and possible relations to sexually dimorphic functions J. Steroid Biochem. Mol. Biol. 40 1991 53 62
72. K. Hagihara, S. Hirata, T. Osada, M. Hirai, and J. Kato Distribution of cells containing progesterone receptor mRNA in the female rat di- and telencephalon: an in situ hybridization study Brain Res. Mol. Brain Res. 14 1992 239 249
73. M. Beato, G. Chalepakis, M. Schauer, and E.P. Slater DNA regulatory elements for steroid hormones J. Steroid Biochem. 32 1989 737 747
74. M. Beato, and J. Klug Steroid hormone receptors: an update Hum. Reprod. Update 6 2000 225 236 (Pubitemid 30348891)
75. A. Sandelin, and W.W. Wasserman Prediction of nuclear hormone receptor response elements Mol. Endocrinol. 19 2005 595 606 (Pubitemid 40349434)
76. L. Martini, V. Magnaghi, and R.C. Melcangi Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system Steroids 68 2003 825 829 (Pubitemid 37532406)
77. M. Schumacher, R. Guennoun, G. Mercier, F. Désarnaud, P. Lacor, J. Bénavides, B. Ferzaz, F. Robert, and E.E. Baulieu Progesterone synthesis and myelin formation in peripheral nerves Brain Res. Brain Res. Rev. 37 2001 343 359 (Pubitemid 34020743)
78. W. Afhüppe, J.M. Beekman, C. Otto, D. Korr, J. Hoffmann, U. Fuhrmann, and C. Möller In vitro characterization of ZK 230211 - A type III progesterone receptor antagonist with enhanced antiproliferative properties J. Steroid Biochem. Mol. Biol. 119 2010 45 55
79. W. Jonat, T. Bachelot, T. Ruhstaller, I. Kuss, U. Reimann, and J.F. Robertson Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer Ann. Oncol. 24 2013 2543 2548
80. C.W. Ip, A. Kroner, J. Groh, M. Huber, D. Klein, I. Spahn, R. Diem, S.K. Williams, K.A. Nave, J.M. Edgar, and R. Martini Neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse PLoS ONE 7 2012 e42554
81. A.S. Tait, C.L. Butts, and E.M. Sternberg The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease J. Leukoc. Biol. 84 2008 924 931
82. T.T. Renault, and S. Manon Bax: Addressed to kill Biochimie 93 2011 1379 1391
83. T. Scholzen, and J. Gerdes The Ki-67 protein: from the known and the unknown J. Cell. Physiol. 182 2000 311 322 (Pubitemid 30054364)
84. B. Lüscher, and J. Vervoorts Regulation of gene transcription by the oncoprotein MYC Gene 494 2012 145 160
85. M. Sereda, I. Griffiths, A. Pühlhofer, H. Stewart, M.J. Rossner, F. Zimmerman, J.P. Magyar, A. Schneider, E. Hund, and H.M. Meinck et al. A transgenic rat model of Charcot-Marie-Tooth disease Neuron 16 1996 1049 1060 (Pubitemid 26171699)
86. R. Fledrich, R.M. Stassart, and M.W. Sereda Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease Br. Med. Bull. 102 2012 89 113
87. A. Schenone, L. Nobbio, M. Monti Bragadin, G. Ursino, and M. Grandis Inherited neuropathies Curr. Treat. Options Neurol. 13 2011 160 179
88. G. Meyer zu Horste, T. Prukop, D. Liebetanz, W. Mobius, K.A. Nave, and M.W. Sereda Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy Ann. Neurol. 61 2007 61 72 (Pubitemid 46214245)
89. K.A. Nave, M.W. Sereda, and H. Ehrenreich Mechanisms of disease: inherited demyelinating neuropathies - from basic to clinical research Nat. Clin. Pract. Neurol. 3 2007 453 464 (Pubitemid 47202502)